Clinical trial
Buprenorphine in the Treatment of Osteoarthritis (OA) in the Elderly
NCT00324038 · Napp Pharmaceuticals Limited, Industry · Completed
Key facts
| NCT number | NCT00324038 |
|---|---|
| Title | Buprenorphine in the Treatment of Osteoarthritis (OA) in the Elderly |
| Official title | An Open, Randomised, Multicentre Study to Compare Buprenorphine Transdermal Delivery System (BTDS) With Standard Treatment in Elderly Subjects With OA of the Hip and/or Knee |
| Lead sponsor | Napp Pharmaceuticals Limited, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Osteoarthritis |
| Intervention type | Drug |
| Interventions | Buprenorphine, Codeine paracetamol |
| Enrollment | 219 |
| Start date | Mar 1, 2006 |
| Completion | Dec 1, 2007 |
| First posted | May 10, 2006 |
| Last update posted | Jun 14, 2011 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: